Infections of COVID-19 are growing or likely growing in half of the U.S. as of July 8, according to CDC estimates.

Painful symptoms caused by a new COVID-19 variant has led to a new nickname: "razor blade throat Covid." Experts say so far, people aren’t likely to get sicker from this variant than others, but that ...

Sept. 2024 photo of Breiona Lang LVN receiving a COVID-19 vaccine from nurse Breiona Lang. left, at a Kaiser Permanente clinic in Venice. (Carlin Stiehl / For The Times) COVID-19 is once again ...

COVID-19 is once again on the rise in California. It remains to be seen whether this latest uptick foreshadows the sort of misery seen last year — when the state was walloped by its worst summertime ...

This is read by an automated voice. Please report any issues or inconsistencies here. California’s summer COVID surge may be peaking as hospital admissions decline, though wastewater levels remain ...

Central California experienced a “very high” COVID-19 test positivity level during August, one of several regions where the virus has been increasingly detected in recent weeks. From Aug. 17-23, ...

Kaiser Permanente, the largest health care provider in the North Bay, began administering the new, updated COVID-19 vaccine this week to its members in Sonoma and Napa counties. The health care giant ...

Looking for information about the FDA’s limited approval of 2025-26 COVID vaccines? Read what we know about who can get an updated COVID shot this year. Updated Aug. 27 If it feels like several people ...

The new XFG "Stratus" COVID-19 variant is now the dominant strain in the U.S. The new strain is driving a recent rise in cases across several states, including California. The variant, a hybrid of two ...

The COVID-19 vaccine, its widespread distribution and eventual herd immunity are the keys to recovering from the coronavirus pandemic and getting back to normal. At least that's the light on the ...

COVID-19 is once again climbing to troubling levels in California — a worrying trend as health officials attempt to navigate a vaccine landscape thrown into uncertainty by delays and decisions from ...